Rigshospitalet Achieves Breakthrough in CNS Tumor Classification

Rigshospitalet, Copenhagen DK

Incredible advancements are taking place at Rigshospitalet Dept of Pathology! πŸŽ‰ We’re now conducting ultra-fast deep CNS tumor classification post-surgery, revolutionizing patient care. 🧠πŸ’₯Massive gratitude to everyone who participated in our GridION Oxford Nanopore Technologies training. Let’s continue pushing boundaries and shaping the future of healthcare together! πŸ’ͺ

Dr. Andreas Venizelos
Dr. Andreas Venizelos
FIELD APPLICATIONS SCIENTIST @ OXFORD NANOPORE TECHNOLOGIES

My research interests include genomic alterations and subclonal evolution dynamics in tumours, as well as the genomic profiling of a hitherto understudied cancer type, gastroenteropancreatic neuroendocrine carcinomas (NECs).